Vaccines for the future?
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000914:Antibodies, Viral / Q000502:physiology; D003906:Developing Countries; D006509:Hepatitis B / Q000628:therapy; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007167:Immunotherapy / Q000191:economics / Q000639:trends*; D007252:Influenza Vaccines / Q000627:therapeutic use; D007251:Influenza, Human / Q000276:immunology / Q000628:therapy; D008458:Measles Vaccine / Q000627:therapeutic use; D051379:Mice; D009500:Neutralization Tests; D009693:Nucleic Acid Hybridization; D009842:Oligopeptides / Q000138:chemical synthesis / Q000276:immunology; D011817:Rabbits; D012411:Rubella Vaccine / Q000627:therapeutic use; D014616:Vaccinia virus / Q000276:immunology; D014765:Viral Vaccines / Q000145:classification / Q000276:immunology / Q000627:therapeutic use*; D014777:Virus Diseases / Q000276:immunology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D007130:Immunoglobulin Idiotypes; D007252:Influenza Vaccines; D008458:Measles Vaccine; D009842:Oligopeptides; D012411:Rubella Vaccine; D014765:Viral Vaccines